Skip to main content
SpringerLink
Log in

Langwirksame β2-Sympathomimetika

Gefahren in der Asthmatherapie ?

  • Leserforum
  • Published:
Monatsschrift Kinderheilkunde Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Anderson HR, Aytes JG, Sturdy PM et al. (2005) Bronchodilator treatment and deaths from asthma: case-control study. BMJ 330: 117–119

    Article  PubMed  Google Scholar 

  2. Ärztliches Zentrum für Qualität in der Medizin (ÄZQ) (2005) Nationale Versorgungsleitlinie Asthma. Dt Ärztebl 40: B2307–B2311

  3. Barnes PJ (1995) Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med 152: 838–860

    PubMed  Google Scholar 

  4. Bateman ED, Boushey HA, Bousquet J et al. (2004) Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma controL (GOAL) study. Am J Respir Crit Care Med (in press)

  5. Berdel et al. AWMF-S2- Leitlinie Asthma bronchiale im Kindesalter. AWMF-Leitlinien-Register Nr. 026/010

  6. Bisgaard H (2000) Long-acting β2-agonists in management of childhood asthma: a critical review of the literature. Pediatr Pulmonol 29: 221–234

    Article  PubMed  Google Scholar 

  7. Bisgaard H (2003) Effect of long-acting beta2 agonists on exacerbation rates of asthma in children. Pediatr Pulmonol 36: 391–398

    Article  PubMed  Google Scholar 

  8. Bisgaard H, Szefler S (2006) Long-acting beta2-agonists and paediatric asthma. Lancet 367: 286–288

    Article  PubMed  Google Scholar 

  9. British Thoracic Society (2003) The british guidelines on asthma management. Asthma in adults and schoolchildren. Thorax 58: 1–94

    Article  Google Scholar 

  10. Buhl R, Berdel D, Criee C-P et al. (2006) Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V. Pneumologie 60: 139–183

    Article  PubMed  Google Scholar 

  11. Castle W, Fuller R, Hall J, Palmer J (1993) Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ 306: 1034–1037

    PubMed  Google Scholar 

  12. Fahy JV, Boushey HA (1995) Controversies involving inhaled beta-agonists and inhaled corticosterids in the treatment of asthma. Clin Chest Med 16: 715–733

    PubMed  Google Scholar 

  13. Gillissen A, Jaworska M, Schärling B, van Zwoll D, Schultze-Werninghaus G (1996) b2-agonists have antioxidant function in vitro (part I). Inhibition of superoxide anion, hydrogen peroxide, hypochlorous acid and hydroxyl radical. Respiration (accepted)

  14. Lurie P, Wolfe SM (2005) Misleading data analysis in salmeterol (SMART) study. Lancet 366: 1261–1262

    Article  PubMed  Google Scholar 

  15. Mann M, Chowdhury BA, Sullivan EJ, Nicklas R, Anthracite R, Meyer RJ (2003) Serious asthma exacerbations in asthmatics treated with high-dose formoterol. Chest 124: 70–74

    Article  PubMed  Google Scholar 

  16. Maris NA, Vos de AF, Dessing MC et al. (2005) Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med 172: 878–884

    Article  PubMed  Google Scholar 

  17. Martinez FD (2005) Safety of long-acting beta-agonists – an urgent need to clear the air. N Engl J Med 353: 2637–2639

    Article  PubMed  Google Scholar 

  18. McCoy L, Redelings M, Sorvillo F, Simon P (2005) A multiple cause-of-death analysis of asthma mortality in the United States, 1990-2001. J Asthma 42: 757–763

    Article  PubMed  Google Scholar 

  19. National Institutes of Health (Hrsg) (2005) Global strategy for asthma management and prevention NHLBI/WHO Workshop report. Bethesda, USA: U.S. Department of Health and Human Services: 1–176 (http://www.ginasthma.com)

    Google Scholar 

  20. Nelson HS (2006) Is there a problem with inhalaed long-acting β-adrenergic agonists ? J Allergy Clin Immunol 117: 3–16

    Article  PubMed  Google Scholar 

  21. Nelson HS, Weiss ST, Bleeker ER, Yancey SW, Dorinsky PM (2006) The salmeterol mulicenter asthma research trial. A comparision of usal pharmacotherapy for asthma or usal pharmacotherapy plus salmeterol. Chest 129: 15–26

    Article  PubMed  Google Scholar 

  22. O’Byrne PM, Ädelroth E (2006) β2 déjà vu. Chest 129: 3–5

    Article  PubMed  Google Scholar 

  23. O’Connor BJ, Aikman SL, Barnes PJ (1992) Tolerance to the nonbronchodilator effects of inhaled beta2-agonists in asthma. N Engl J Med 328: 665–666

    Google Scholar 

  24. Palmer CN, Lipworth BJ, Lee S, Ismail T, Macgregor DF, Mukhopadhyay S (2006) The arginine-16 beta 2 adrenoceptor genotype predisposis to exacerbations in young asthmatics taking regular salmeterol. Thorax e-publication

  25. Pauwels RA, Calverley PMA, Vestbo J et al. (2002) Reduction of exacerbations with salmeterol/fluticasone combination 50/500 mcg bd in the treatment of chronic obstrucitve pulmonary diasease (COPD) (abst.). Eur Respir J 20: 241s

    Google Scholar 

  26. Pauwels RA, Löfdahl C-G, Postma DS et al. (1997) Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 337: 1405–1411

    Article  PubMed  Google Scholar 

  27. Rickard KA (2005) Misleading data analysis in salmeterol (SMART) study: GlaxoSmithklin’s reply. Lancet 366: 1262

    Article  Google Scholar 

  28. Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE (2006) Meta-Analysis: Effect of long-acting β-agonists on severe-asthma exacerbations and asthma-related deaths. Ann Intern Med 144: 904–912

    PubMed  Google Scholar 

  29. Salpeter SR, Ormiston TM, Salpeter EE (2004) Meta-analysis: respiratory tolerance to regular β2-agnoist use in patients with asthma. Ann Intern Med 140: 802–813

    PubMed  Google Scholar 

  30. Sears M (2000) Consequences of long-term inflammation. The natural history of asthma. Clin Chest Med 21: 315–329

    Article  PubMed  Google Scholar 

  31. Sears MR, Taylor DR, Print CG et al. (1990) Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336: 1391–1396

    Article  PubMed  Google Scholar 

  32. Suissa S, Ernst P, Benayoun S, Baltzan M, Sci B (2000) Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 343: 332–336

    Article  PubMed  Google Scholar 

  33. Suissa S, Hemmelgarn B, Blais L, Ernst P (1996) Bronchodilators and acute cardiac death. Am J Respir Crit Care Med 154: 1598–1602

    PubMed  Google Scholar 

  34. Tal A, Simon G, Vermeulen JH et al. (2002) Budesonid/Formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma. Pediatr Pulmonol 34: 342–350

    Article  PubMed  Google Scholar 

  35. Verberne AA, Frost C, Duiverman EJ, Grol MH, Kerrebijn KF (1998) Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. Am J Respir Crit Care Med 158: 213–219

    PubMed  Google Scholar 

  36. Wechsler ME, Israel E (2005) How pharmacogenomics will play a role in the management of asthma. Am J Respir Crit Care Med 172: 12–18

    Article  PubMed  Google Scholar 

  37. Wolfe J, LaForce CF, Sokol W, Orevillo C, Till D (2006) Formoterol, 24 µg bid, and serious asthma exacerbations: similar rates compared with formoterol, 12 µg bid, with and without extra doses taken on demand, and placebo. Chest 129: 27–38

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dr. von Haunersches Kinderspital, Klinikum der LMU München, Lindwurmstr. 4, 80337, München, Deutschland

    D. Reinhardt

Authors
  1. D. Reinhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

D. Berdel, A. Schuster, A. von Berg, M. Gappa, F. Friedrichs, J. Freihorst, J. Forster, F. Riedel, E. Rietschel, Christoph Runge, R. Szczepanski, W. Wahlen, U. Wahn

Corresponding author

Correspondence to D. Reinhardt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reinhardt, D., D. Berdel, A. Schuster, A. von Berg, M. Gappa, F. Friedrichs, J. Freihorst, J. Forster, F. Riedel, E. Rietschel, Christoph Runge, R. Szczepanski, W. Wahlen, U. Wahn. Langwirksame β2-Sympathomimetika . Monatsschr Kinderheilkd 154, 910–911 (2006). https://doi.org/10.1007/s00112-006-1402-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00112-006-1402-8

Search

Navigation